Key result
Oudejans algorithm improves non-acute HF diagnostic reclassification ~22% over 2012 ESC criteria in patients aged >=80.
Why the study?
Different diagnostic algorithms for non-acute heart failure in symptomatic patients aged 80 years and older have varying accuracy and need comparison and validation.
Cohort (n=365)
Single-blind
Yes
Effect estimate: NRI 22% (95% CI 9% to 32%)
p-value: p=<0.001
May improve reclassification and reduce referrals in symptomatic octogenarians; leaves open prospective validation of outcomes.
OBJECTIVES: Different diagnostic algorithms for non-acute heart failure (HF) exist. Our aim was to compare the ability of these algorithms to identify HF in symptomatic patients aged 80 years and older and identify those patients at highest risk for mortality. DESIGN: Diagnostic accuracy and validation study. SETTING: General practice, Belgium. PARTICIPANTS: 365 patients with HF symptoms aged 80 years and older (BELFRAIL cohort). Participants underwent a full clinical assessment, including a detailed echocardiographic examination at home. OUTCOME MEASURES: The diagnostic accuracy of 4 different algorithms was compared using an intention-to-diagnose analysis. The European Society of Cardiology (ESC) definition of HF was used as the reference standard for HF diagnosis. Kaplan-Meier curves for 5-year all-cause mortality were plotted and HRs and corresponding 95% CIs were calculated to compare the mortality risk predicting abilities of the different algorithms. Net reclassification improvement (NRI) was calculated. RESULTS: The prevalence of HF was 20% (n=74). The 2012 ESC algorithm yielded the highest sensitivity (92%, 95% CI 83% to 97%) as well as the highest referral rate (71%, n=259), whereas the Oudejans algorithm yielded the highest specificity (73%, 95% CI 68% to 78%) and the lowest referral rate (36%, n=133). These differences could be ascribed to differences in N-terminal probrain natriuretic peptide cut-off values (125 vs 400 pg/mL). The Kelder and Oudejans algorithms exhibited NRIs of 12% (95% CI 0.7% to 22%, p=0.04) and 22% (95% CI 9% to 32%, p<0.001), respectively, compared with the ESC algorithm. All algorithms detected patients at high risk for mortality (HR 1.9, 95% CI 1.4 to 2.5; Kelder) to 2.3 (95% CI 1.7 to 3.1; Oudejans). No significant differences were observed among the algorithms with respect to mortality risk predicting abilities. CONCLUSIONS: Choosing a diagnostic algorithm for non-acute HF in elderly patients represents a trade-off between sensitivity and specificity, mainly depending on differences between cut-off values for natriuretic peptides.
No takes yet. Share an insight, caveat, or question.
Smeets et al. (2016) conducted a cohort in Non-acute heart failure (n=365). Oudejans diagnostic algorithm vs. 2012 ESC diagnostic algorithm was evaluated on Diagnosis of heart failure (Net Reclassification Improvement) (NRI 22%, 95% CI 9% to 32%, p=<0.001). The Oudejans diagnostic algorithm yielded a net reclassification improvement of 22% compared to the 2012 ESC algorithm for diagnosing non-acute heart failure in symptomatic patients aged 80 years and older.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: